Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    [Intravesical botulinum toxin under local anestesia as ambulatory procedure.]

    Arch Esp Urol 2017 Sep;70(7):635-644
    Servicio de Urología. Hospital Universitario Ramón y Cajal. Universidad de Alcalá de Henares. Madrid. IRYCIS.España.
    Bladder hyperactivity is described as the presence of "voiding urgency, generally associated with increased daytime frequency and nocturia, with or without urinary incontinence, in the absence of urinary tract infection or other obvious pathology". Onabotulinum toxin A (BTA) is a recommendable therapeutic option in case of failure, contraindication or refusal of the conservative therapy or other non-pharmacological therapies. The injection of BTA in the detrusor has been performed under local, regional or general anesthesia either in the conventional or major ambulatory surgery operative room or in the cystoscopy room. The objective of this paper is to describe the procedure to perform BTA therapy as an ambulatory operation under intravesical local anesthesia in the cystoscopy room, describing its advantages and limitations.

    Similar Publications

    Botulinum toxin injections for adults with overactive bladder syndrome.
    Cochrane Database Syst Rev 2011 Dec 7(12):CD005493. Epub 2011 Dec 7.
    Wellington Hospital, Riddiford Street, Newtown, Wellington, New Zealand, 6021.
    Background: Overactive bladder syndrome (OAB) is a common condition with a significant negative impact on quality of life characterised by urgency with or without urge incontinence, frequency and nocturia.  Intravesical botulinum toxin is being increasingly used to treat severe overactive bladder refractory to standard management.  An increasing body of literature is forming that supports this technique as effective, well tolerated, and safe. Read More
    Botulinum toxin injections in the management of non-neurogenic overactive bladders in children.
    J Pediatr Surg 2014 Sep 14;49(9):1424-8. Epub 2014 May 14.
    Pediatric Surgery Department, American Hospital, CHU de Reims, France.
    Introduction: Non-neurogenic detrusor overactivity in children leads to varying degrees of functional impairments (urinary urgency, pollakiuria, urge incontinence, nocturia). Botulinum toxin has shown its effectiveness in the management of detrusor overactivity in neurological patients.

    Objectives: To evaluate the relevance of intravesical Botulinum toxin injections for the treatment of non-neurogenic overactive bladders in children. Read More
    Botulinum toxin injections for adults with overactive bladder syndrome.
    Cochrane Database Syst Rev 2007 Jul 18(3):CD005493. Epub 2007 Jul 18.
    Background: Overactive bladder syndrome is a common condition with a significant negative impact on quality of life. Intravesical injection of botulinum toxin is increasingly used as an intervention for refractory overactive bladder, with a considerable body of case reports and series in the literature suggesting beneficial effects.

    Objectives: The objective was to compare intravesical botulinum toxin injection with other treatments for neurogenic and idiopathic overactive bladder in adults. Read More
    Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.
    Neurourol Urodyn 2016 Feb 18;35(2):267-70. Epub 2014 Dec 18.
    Département d'Urologie, Transplantation Rénale et Andrologie, CHU Rangueil, Toulouse, France.
    Aims: To assess the results of onabotulinum toxin detrusor injections when abobotulinum toxin detrusor injection failed.

    Methods: Twenty-six patients, 15 women and 11 men, mean age 40.8 ± 12. Read More